Your Article Summary
See Latest ArticlesPharmacogenetics in heart failure: promises and challenges
Expert Opinion in Pharmacotherapy, 06/30/09
Boer RAD et al. - Prospective large-scale pharmacogenetic studies are warranted as authors believe that they will identify new targets for therapy and specific populations that benefit from specific treatments.
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
Vascular Health and Risk Management, 12/01/09
Multaq Approved in the European Union for Patients with Atrial Fibrillation
Sanofi-aventis, 12/01/09
Vernakalant hydrochloride for the treatment of atrial fibrillation
Expert Opinion on Investigational Drugs, 11/30/09